ÂÜÀòÂÒÂ×

Craig Freyer, Pharm.D, BCOP has a diverse work experience in the field of hematology/oncology pharmacy. Their most recent role is as a Field Medical Director for the Menin Inhibitor Program at Syndax Pharmaceuticals, starting in May 2023. Prior to that, they served as an Adjunct/Guest Lecturer and Clinical Preceptor in Hematology/Oncology at Thomas Jefferson University from March 2016 to April 2023. From October 2015 to April 2023, they worked as a Clinical Pharmacy Specialist in Hematology/Oncology, Stem Cell Transplant, and Cellular Therapy at Penn Medicine, University of Pennsylvania Health System. Craig also held a position as a Clinical Pharmacy Specialist in the Leukemia Service at Roswell Park Cancer Institute from August 2012 to September 2015. Additionally, they completed a Hematology/Oncology Pharmacy Residency at Moffitt Cancer Center from July 2011 to June 2012 and a Pharmacy Practice Residency at HENRY FORD HEALTH-MAIN HOSPITAL from July 2010 to June 2011. Throughout their career, Craig Freyer has focused on providing specialized pharmacy care to patients with cancer.

Craig Freyer, Pharm.D, BCOP began their education journey in 2004 at the University of Connecticut, where they pursued a Doctor of Pharmacy (Pharm.D.) degree in Pharmacy. Craig received their degree in 2010. Additionally, they obtained the certification of Board Certified Oncology Pharmacist from the BPS - Board of Pharmacy Specialties. The month and year of obtaining the certification are not specified.